Fig. 3From: Assessment of interactions of efavirenz solid drug nanoparticles with human immunological and haematological systemsExtent of haemolysis in healthy volunteer blood treated with efavirenz aqueous solution and efavirenz SDN. Healthy volunteer blood was treated with a range of concentrations of test materials for 3 h at 37 °C. Percent haemolysis was determined by assessing the amount of free haemoglobin present in samples post incubationBack to article page